Ajax-Loading

Novartis AG - Other Long Term Liabilities

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Long-Term-Liabilities" stands at 4.13 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Other Long Term Liabilities" stands at 4.13 Billion USD. This represents a decrease of -2.69 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.95 percent compared to the value the year prior.
The 1 year change in percent is -5.95.

The Serie's long term average value is 3.02 Billion United States Dollars. It's latest available value, on 09/30/2025, is 36.83 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +296.54%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -14.68%.

Other Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Other Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Long Term Liabilities280,205,508,085.11